Zapata-Tarrés M, López-Corella E, Pérez-García M, Rivera-Luna R

Language: Spanish
References: 7
Page: 45-54
PDF size: 497.73 Kb.

Text Extraction

REFERENCES

1. Castro-Malespina H, Schaison G, Briere J, Passe S, Pasquier A, et al. Philadelphia chromosome-positive chronic myeloid leukemia in children: survival and prognostic features. Cancer 1983;52:721.

2. Gartner JG. Thymic involution with loss of Hassall’s corpuscles mimicking thymic dysplasia in a child with transfusion-associated graft-versus-host disease. Pediatr Pathol 1991;11:449-456.

3. Hughes TP, Hochhaus A, Bradford S, Muller MC, Kaeda JS, et al. Long-term prognostic significance of early molecular response to imatinib in neuly diagnosed chronic myeloid leukemia. Blood 2010;116:3758-3765.

4. Lichtman MA. Is There an entity of chemically induced BCRABL– positive chronic myelogenous leukemia? The Oncologist 2008;13:645-654.

5. Ortiz-Hidalgo C. Notas sobre la historia de la leucemia. Patología 2013;51:58-89.

6. Rowley JD. A new consistent chromosomal abnormality in chronic muelogenous leukaemia identified by quinacrine fluoresence and Giensa staining. Nature 1973;1:290-293.

7. Vigneri P, Wang JY. Induction of apoptosis in chronic myeloid leukemia cells through nuclear entrapment of BCR-ABL tyrosin kinase. Nat Med 2001;7:228-234.